Inspec

Inspec EBITDA per Employee

The EBITDA per Employee of Inspec (6656.T) as of Oct 21, 2026 is 1.89 M JPY. In the previous year, EBITDA per Employee was 1.40 M JPY — a change of 34.47% (higher).

EBITDA per Employee

1.89 MJPY

YoY

34.47%

Last updated:

EBITDA per Employee of Inspec is 2026 1.89 M JPY. EBITDA per Employee of Inspec was 2025 1.40 M JPY. It decreases by 34.47% higher compared to the previous year.

The Inspec EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2019
3.77 M JPY
Jan 1, 2020
1.96 M JPY
Jan 1, 2021
-3.17 M JPY
Jan 1, 2022
356,642.86 JPY
Jan 1, 2023
1.90 M JPY
Jan 1, 2024
-2.63 M JPY
Jan 1, 2025
1.40 M JPY
Jan 1, 2026
1.89 M JPY
The Inspec EBITDA per Employee history
YEAREBITDA per EmployeeYoY
1.89 MJPY+34.47%
1.40 MJPY-153.46%
-2.63 MJPY-238.39%
1.90 MJPY+432.05%
356,642.86JPY-111.27%
-3.17 MJPY-261.54%
1.96 MJPY-48.02%
3.77 MJPY-225.39%
-3.01 MJPY-254.58%
1.94 MJPY-932.37%
-233,642.86JPY-118.35%
1.27 MJPY+85.93%
684,630.95JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inspec Stock analysis

What does Inspec do? inspec Inc. generates revenue through three primary segments. The Semiconductor Package Substrates and Precision Substrate Inspection Equipment segment sells appearance inspection equipment for semiconductor package substrates and precision printed circuit boards used in smartphones, tablets, PCs, and wearable terminals. The Precision Substrate Manufacturing Equipment segment provides photoplotters, inkjet printers, and direct imaging devices along with maintenance services for printed circuit boards. The Digital Pathology Related Equipment segment develops and sells medical image processing systems, specifically whole slide imaging (WSI) for digital pathology applications. Customers include manufacturers of advanced digital devices requiring semiconductor inspection, PCB producers needing photoplotters and imaging devices, and healthcare providers utilizing whole slide imaging systems for pathology diagnostics. The company's products target the semiconductor, electronics manufacturing, and medical imaging sectors with specific applications in device assembly, PCB production, and medical diagnostics. inspec Inc. focuses on equipment for semiconductor package substrates, precision substrates, and digital pathology, serving clients in the electronics and healthcare industries. The firm's inspection and imaging solutions are tailored to meet the quality control needs of high-tech manufacturing and medical diagnostics, with no mention of additional revenue streams beyond these three segments. Inspec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inspec stock

EBITDA per Employee of Inspec is 1.89 M JPY in 2026.

EBITDA per Employee of Inspec changed from 1.40 M JPY to 1.89 M JPY, representing a 34.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Inspec since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Inspec historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Inspec

All Key Metrics — Inspec